339 related articles for article (PubMed ID: 24500787)
1. The OPTI-MIND study: a prospective, observational study of pacemaker patients according to pacing modality and primary indications.
Biffi M; Melissano D; Rossi P; Kaliska G; Havliĉek A; Pelargonio G; Romero R; Guastaferro C; Menichelli M; Vireca E; Frisoni J; Boriani G; Malacky T
Europace; 2014 May; 16(5):689-97. PubMed ID: 24500787
[TBL] [Abstract][Full Text] [Related]
2. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study.
Chen S; Chen K; Tao Q; Zheng L; Shen F; Wu S; Fan J; Xu G; Wang L; Zhou X; Zhang S;
Europace; 2014 Nov; 16(11):1595-602. PubMed ID: 24706091
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity-a sub-study of the ANSWER trial.
Stockburger M; Defaye P; Boveda S; Stancak B; Lazarus A; Sipötz J; Nardi S; Rolando M; Moreno J
Europace; 2016 May; 18(5):739-46. PubMed ID: 26612882
[TBL] [Abstract][Full Text] [Related]
4. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
[TBL] [Abstract][Full Text] [Related]
5. A comparison of AAIR versus DDDR pacing for patients with sinus node dysfunction: a long-term follow-up study.
Mutagaywa RK; Tumaini B; Chin A
Cardiovasc J Afr; 2021 Jan-Feb 23; 32(1):17-20. PubMed ID: 32946543
[TBL] [Abstract][Full Text] [Related]
6. Atrial pacing site and atrioventricular conduction in patients paced for sinus node disease.
Watabe T; Abe H; Kohno R; Oginosawa Y; Hayashi K; Ohe H; Tamura M; Takeuchi M; Otsuji Y
J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1224-31. PubMed ID: 24946835
[TBL] [Abstract][Full Text] [Related]
7. Minimizing right ventricular pacing in patients with sinus node disease and prolonged PQ interval: The impact on exercise capacity.
Krzyżanowski K; Michałkiewicz D; Orski Z; Wierzbowski R; Ryczek R; Cwetsch A
Cardiol J; 2015; 22(1):75-9. PubMed ID: 24846513
[TBL] [Abstract][Full Text] [Related]
8. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block.
Gillis AM; Pürerfellner H; Israel CW; Sunthorn H; Kacet S; Anelli-Monti M; Tang F; Young M; Boriani G;
Pacing Clin Electrophysiol; 2006 Jul; 29(7):697-705. PubMed ID: 16884504
[TBL] [Abstract][Full Text] [Related]
9. Near elimination of ventricular pacing in SafeR mode compared to DDD modes: a randomized study of 422 patients.
Davy JM; Hoffmann E; Frey A; Jocham K; Rossi S; Dupuis JM; Frabetti L; Ducloux P; Prades E; Jauvert G
Pacing Clin Electrophysiol; 2012 Apr; 35(4):392-402. PubMed ID: 22309303
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of first-degree AV-block in patients with sinus node dysfunction: data from the mode selection trial.
Holmqvist F; Hellkamp AS; Lee KL; Lamas GA; Daubert JP;
Pacing Clin Electrophysiol; 2014 Sep; 37(9):1111-9. PubMed ID: 24797760
[TBL] [Abstract][Full Text] [Related]
11. AAIsafeR limits ventricular pacing in unselected patients.
Pioger G; Leny G; Nitzsché R; Ripart A
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S66-70. PubMed ID: 17302721
[TBL] [Abstract][Full Text] [Related]
12. Minimizing ventricular pacing by a novel atrioventricular (AV) delay hysteresis algorithm in patients with intact or compromised intrinsic AV conduction and different atrial and ventricular lead locations.
Pakarinen S; Toivonen L
Ann Med; 2013 Sep; 45(5-6):438-45. PubMed ID: 23768003
[TBL] [Abstract][Full Text] [Related]
13. Effect of a pacing mode preserving spontaneous AV conduction on ventricular pacing burden and atrial arrhythmias.
Rey JL; Quenum S; Hero M
Pacing Clin Electrophysiol; 2012 May; 35(5):580-5. PubMed ID: 22339661
[TBL] [Abstract][Full Text] [Related]
14. Reduction of right ventricular pacing in patients with sinus node dysfunction through programming a long atrioventricular delay along with the DDIR mode.
Nitardy A; Langreck H; Dietz R; Stockburger M
Clin Res Cardiol; 2009 Jan; 98(1):25-32. PubMed ID: 18853096
[TBL] [Abstract][Full Text] [Related]
15. The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale.
Pastore G; Bertini M; Bonanno C; Coluccia G; Dell'Era G; De Mattia L; Grieco D; Katsouras G; Maines M; Marcantoni L; Marinaccio L; Paglino G; Palmisano P; Ziacchi M; Zoppo F; Noventa F
Europace; 2023 May; 25(5):. PubMed ID: 36974970
[TBL] [Abstract][Full Text] [Related]
16. [Retrospective analysis of 1650 permanent pacemaker implantations experience over two different consecutive time periods in a single cardiology clinic].
Bayata S; Yeşil M; Arikan E; Postaci N; Berilğen R; Ceylan O; Avci E
Anadolu Kardiyol Derg; 2010 Apr; 10(2):130-4. PubMed ID: 20382611
[TBL] [Abstract][Full Text] [Related]
17. Trend of the main clinical characteristics and pacing modality in patients treated by pacemaker: data from the Italian Pacemaker Registry for the quinquennium 2003-07.
Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Zakja E; Gulizia M; Esente P
Europace; 2010 Feb; 12(2):202-9. PubMed ID: 19903671
[TBL] [Abstract][Full Text] [Related]
18. Long-term progression of rhythm and conduction disturbances in pacemaker recipients: findings from the Pacemaker Expert Programming study.
Palmisano P; Ziacchi M; Ammendola E; Dell'Era G; Guerra F; Aspromonte V; Boriani G; Nigro G; Occhetta E; Capucci A; Ricci RP; Maglia G; Biffi M; Accogli M;
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):357-365. PubMed ID: 29846304
[TBL] [Abstract][Full Text] [Related]
19. Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients.
Arnold M; Richards M; D'Onofrio A; Faulknier B; Gulizia M; Thakur R; Sakata Y; Lin W; Pollastrelli A; Grammatico A; Auricchio A; Boriani G
Europace; 2023 May; 25(5):. PubMed ID: 36942949
[TBL] [Abstract][Full Text] [Related]
20. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
